Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Health Technology Holding (HTH)

Status
ACTIVE
Global HQ
Italy
Countries of investment
  • USA
  • Canada
  • Israel
Investment stages
  • Pre-Seed
  • Seed
  • Series A
  • Series B
Industries
  • Health Tech
  • AI
  • Biotechnology
  • Blockchain
About
HTH is a global venture capital firm investing in Life Science Innovation, specializing in Medtech, Biotech, and Digital Health technologies.
Min check size
$500K
Max check size
$1M
Fund size
NPS

Investment Thesis

HTH’s investment thesis revolves around identifying and supporting companies with groundbreaking technologies in the health tech sector. The firm seeks to invest in startups that are developing solutions with the potential to transform healthcare, including digital health platforms, medical devices, and health IT systems.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With extensive experience in private equity, the fund manager has built a strong portfolio across key sectors such as technology, healthcare, and consumer goods. Actively investing in North American and European markets, they have successfully executed over 30 deals with a focus on growth equity and buyouts. Their operator-first approach has led to notable exits, maximizing returns while fostering strategic partnerships. The manager employs a data-driven strategy, ensuring informed decision-making and sustainable value creation.

Health Technology Holding (HTH) Contacts Information

Primary contact

Team

Michele Gaiotto

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp